REPLIGEN CORP

RGEN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $6.6B · 2,000 employees
289
SEC Filings
$147.01
Close 2026-06-26
2,000
Employees

Business Summary

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems for biological drug manufacturing. Products span four franchises: Filtration (XCell ATF, KrosFlo TFF, hollow fiber filters), Chromatography (OPUS columns, BioSMB systems), Process Analytics (FlowVPX, SciLog), and Proteins (Protein A ligands). Customers include global biopharmaceutical companies, contract development and manufacturing organizations, and life science integrators producing mAbs, RNA therapeutics, vaccines, and cell and gene therapies.

Latest Stock Quote

RGEN 2026-06-26 $147.01 O:$143.98 H:$147.585 L:$143.98 Vol:2.0M VWAP:$146.2811
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076528EDGAR62K words
2025-03-142024-12-310000950170-25-038999EDGAR
2024-02-222023-12-310000950170-24-018809EDGAR
2023-02-222022-12-310000950170-23-003793EDGAR
2022-02-172021-12-310000950170-22-001430EDGAR
2021-02-242020-12-310001193125-21-054675EDGAR
2020-02-262019-12-310001193125-20-050136EDGAR
2019-03-012018-12-310001193125-19-060645EDGAR
2018-02-222017-12-310001193125-18-054262EDGAR
2017-02-232016-12-310001193125-17-054220EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-07-292026-06-300001193125-26-323773EDGAR
2025-11-042025-09-300001193125-25-264666EDGAR26K words
2025-08-072025-06-300000950170-25-105166EDGAR
2025-04-292025-03-310000950170-25-060156EDGAR
2024-11-182024-09-300000950170-24-127846EDGAR
2024-07-302024-06-300000950170-24-087981EDGAR
2024-05-012024-03-310000950170-24-051310EDGAR
2023-10-312023-09-300000950170-23-056871EDGAR
2023-08-022023-06-300000950170-23-037204EDGAR
2023-05-022023-03-310000950170-23-016729EDGAR
2022-11-012022-09-300000950170-22-020864EDGAR
2022-08-022022-06-300000950170-22-013883EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-280001193125-26-318853EDGAR
2026-07-220001193125-26-311402EDGAR
2026-02-240001193125-26-065246EDGAR9K words
2026-01-060001193125-26-003467EDGAR
2025-10-280001193125-25-252385EDGAR
2025-09-020001193125-25-193481EDGAR
2025-07-290000950170-25-099389EDGAR
2025-05-150000950170-25-072664EDGAR
2025-04-290000950170-25-059569EDGAR
2025-02-200000950170-25-023742EDGAR

289 total filings indexed. 257 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

biopharmaceutical-manufacturing contract-development-and-manufacturing-organizations-(cdmos) monoclonal-antibodies-and-mab-derivatives cell-and-gene-therapy-manufacturing rna-based-therapeutics-and-vaccines recombinant-proteins cgmp-(current-good-manufacturing-practice) single-use/single-campaign-bioprocessing closed-system-technologies

Company Identity

CIK0000730272
TickerRGEN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
HeadquartersWaltham, Massachusetts
Websitehttps://www.repligen.com
Listed1986-04-29

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9ddc9221ca211844521bb5b9684924e14b91a49ce6d5a81552ff00ba210a153d
parent: e05cad78d5960e809fe03379a35feddf9b1b15c2bcb0ee331d08a4f1794a08f4
content hash: 8f2ee1d5dd94f92cac3f4dabdbca160e98a7a2251e7d9b76ed67bf9ad42e0098
signed: 2026-08-11T19:06:30.670Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up RGEN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on RGEN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/RGEN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.